» Articles » PMID: 10330164

Specificity of Cyclin E-Cdk2, TFIIB, and E1A Interactions with a Common Domain of the P300 Coactivator

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 May 18
PMID 10330164
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The p300 and CREB binding protein (CBP) transcriptional coactivators interact with a variety of transcription factors and regulate their activity. Among the interactions that have been described, the COOH-terminal region of p300 binds to cyclin E-cyclin-dependent kinase 2 (cyclin E-Cdk2) and TFIIB, as well as to the E1A gene products of adenovirus. Inhibition of Cdk activity by Cdk inhibitors, such as p21 or p27, potentiates NF-kappaB activity and provides a mechanism to coordinate cell cycle progression with the transcription of genes expressed during growth arrest. In this report, we analyze the specific domains of p300 required for the binding of p300 to cyclin E-Cdk2, TFIIB, and E1A and the ability of these proteins to interact with p300, alone or in combination. 12S E1A, an inhibitor of p300-dependent transcription, reduces the binding of TFIIB, but not that of cyclin E-Cdk2, to p300. In contrast, 13S E1A, a pleiotropic transcriptional activator, does not inhibit TFIIB binding to p300, although it enhances the interaction of cyclin E-Cdk2 with p300. Modification of cyclin E-Cdk2 is most likely required for association with p300 since the interaction is observed only with cyclin E-Cdk2 purified from mammalian cells. Domain swap studies show that the cyclin homology domain of TFIIB is involved in interactions with p300, although the homologous region from cyclin E does not mediate this interaction. These findings suggest that p300 or CBP function is regulated by interactions of various proteins with a common coactivator domain.

Citing Articles

Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo.

Odajima J, Saini S, Jung P, Ndassa-Colday Y, Ficaro S, Geng Y PLoS Genet. 2016; 12(11):e1006429.

PMID: 27828963 PMC: 5102403. DOI: 10.1371/journal.pgen.1006429.


Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.

Wang F, Marshall C, Ikura M Cell Mol Life Sci. 2013; 70(21):3989-4008.

PMID: 23307074 PMC: 11113169. DOI: 10.1007/s00018-012-1254-4.


Increased expression of transcription initiation factor IIB after rat traumatic brain injury.

Liu Z, Wang D, Shao B, Wu X, Xu J, Lu Q J Mol Histol. 2011; 42(3):265-71.

PMID: 21544596 DOI: 10.1007/s10735-011-9330-x.


The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB.

Vogt C, Preuss E, Mayer D, Weber F, Schwemmle M, Kochs G J Virol. 2008; 82(22):11446-53.

PMID: 18768974 PMC: 2573285. DOI: 10.1128/JVI.01284-08.


Dysregulation of CREB binding protein triggers thrombin-induced proliferation of vascular smooth muscle cells.

Chen J, Jiang H, Xu L, Zhu L, Wang L, Wen H Mol Cell Biochem. 2008; 315(1-2):123-30.

PMID: 18496732 DOI: 10.1007/s11010-008-9795-4.


References
1.
Lee W, Kao C, Bryant G, Liu X, Berk A . Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell. 1991; 67(2):365-76. DOI: 10.1016/0092-8674(91)90188-5. View

2.
Abraham S, Lobo S, Yaciuk P, Wang H, Moran E . p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene. 1993; 8(6):1639-47. View

3.
Barberis A, Muller C, Harrison S, Ptashne M . Delineation of two functional regions of transcription factor TFIIB. Proc Natl Acad Sci U S A. 1993; 90(12):5628-32. PMC: 46774. DOI: 10.1073/pnas.90.12.5628. View

4.
Yamashita S, Hisatake K, Kokubo T, Doi K, Roeder R, Horikoshi M . Transcription factor TFIIB sites important for interaction with promoter-bound TFIID. Science. 1993; 261(5120):463-6. DOI: 10.1126/science.8332911. View

5.
Malik S, Lee D, Roeder R . Potential RNA polymerase II-induced interactions of transcription factor TFIIB. Mol Cell Biol. 1993; 13(10):6253-9. PMC: 364684. DOI: 10.1128/mcb.13.10.6253-6259.1993. View